⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propane SCHEMBL21383285 | 0.71 | — | — | |
| SCHEMBL2729568 | 0.67 | — | — | |
| SCHEMBL49670 | 0.59 | — | — | |
| SCHEMBL208611 | 0.59 | — | — | |
| SCHEMBL8385848 | 0.59 | — | — | |
| SCHEMBL23701279 | 0.58 | — | — | |
| SCHEMBL21357940 | 0.56 | — | — | |
| SCHEMBL2462818 | 0.56 | — | — | |
| SCHEMBL21773390 | 0.56 | — | — | |
| Hydrochloric Acid SCHEMBL1032031 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11784043-B2 | Formation of SiN thin films | ASM IP Holding, B.V. (NL) | 2023-10-10 | — | — | US | disclosed |
| CN-111344314-B | Modified conjugated diene polymer and preparation method thereof | 株式会社LG化学 | 2023-01-03 | — | — | CN | disclosed |
| US-11367613-B2 | Deposition of SiN | ASM IP HOLDING B.V. (NL) | 2022-06-21 | — | — | US | disclosed |
| US-11289327-B2 | Si precursors for deposition of SiN at low temperatures | ASM IP HOLDING B.V. (NL) | 2022-03-29 | — | — | US | disclosed |
| US-11251035-B2 | Method of forming a structure on a substrate | ASM IP HOLDING B.V. (NL) | 2022-02-15 | — | — | US | disclosed |
| US-8034814-B2 | Phthalazine derivatives with angiogenesis inhibiting activity | NOVARTIS AG (CH) | 2011-10-11 | — | — | US | disclosed |
| US-20110130399-A1 | Phthalazine Derivatives with Angiogenesis Inhibiting Activity | NOVARTIS AG (CH) | 2011-06-02 | — | — | US | disclosed |
| WO-2006078698-A1 | 2-IMIDAZOLONE AND 2-IMIDAZOLIDINONE HETEROCYCLIC INHIBITORS OF TYROSINE PHOSPHATASES | CENGENT THERAPEUTICS, INC. (US) | 2006-07-27 | — | — | WO | disclosed |
| EP-1153034-A1 | GROWTH HORMONE SECRETAGOGUES | ELI LILLY AND COMPANY (US) | 2001-11-14 | — | — | EP | disclosed |
| WO-2000049037-A1 | GROWTH HORMONE SECRETAGOGUES | ELI LILLY AND COMPANY (US) | 2000-08-24 | — | — | WO | disclosed |
| EP-0929534-A1 | TRYCYCLIC COMPOUNDS AS PROSTAGLANDIN I2 RECEPTOR AGONISTS | Takeda Pharmaceutical Company Limited (JP) | 1999-07-21 | — | — | EP | disclosed |
| EP-0639977-A4 | LIPID-A ANALOGS: NEW MONOSACCHARIDE AND DISACCHARIDE INTERMEDIATES FOR ELICITING THERAPEUTIC ANTIBODIES AND FOR ANTITUMOR AND ANTIVIRAL ACTIVITIES. | IGEN INC (US) | 1999-04-14 | — | — | EP | disclosed |
| WO-1998013356-A1 | TRYCYCLIC COMPOUNDS AS PROSTAGLANDIN I2 RECEPTOR AGONISTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1998-04-02 | — | — | WO | disclosed |
| EP-0639977-A1 | LIPID-A ANALOGS: NEW MONOSACCHARIDE AND DISACCHARIDE INTERMEDIATES FOR ELICITING THERAPEUTIC ANTIBODIES AND FOR ANTITUMOR AND ANTIVIRAL ACTIVITIES | IGEN, INC. (US) | 1995-03-01 | — | — | EP | disclosed |
| EP-0623113-A1 | PYRAZOLE CARBOXANILIDE FUNGICIDES. | MONSANTO CO (US) | 1994-11-09 | — | — | EP | disclosed |
| WO-1993019761-A1 | LIPID-A ANALOGS: NEW MONOSACCHARIDE AND DISACCHARIDE INTERMEDIATES FOR ELICITING THERAPEUTIC ANTIBODIES AND FOR ANTITUMOR AND ANTIVIRAL ACTIVITIES | IGEN, INC. (US) | 1993-10-14 | — | — | WO | disclosed |
| EP-0460062-A4 | METHOD FOR THE SYNTHESIS OF HUPERZINE A AND ANALOGS THEREOF AND COMPOUNDS USEFUL THEREIN | — | 1992-07-01 | — | — | EP | disclosed |